Discordance between sputum eosinophil counts and exhaled nitric oxide levels in asthma Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Inflammation and diagnosis of asthma: exhaled nitric oxide (FENO ) and induced sputum eosinophil count Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005
Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013
Eosinophil and neutrophilic chemotactic activity in the exhaled breath condensate of stable patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults Source: Eur Respir J 2007; 30: 769-781 Year: 2007
Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO Source: Eur Respir J 2004; 24: Suppl. 48, 578s Year: 2004
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018
Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006
Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003